Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 51501-51550 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT04903353
Pragmatic Trial Comparing Weight Gain in Children With Autism Taking Risperidone Versus Aripiprazole
PHASE4
Recruiting
350 participants
Started: Feb 1, 2022 · Completed: Dec 1, 2025
3 conditions
1 sponsor
1 location
NCT04456569
Geniculate Artery Embolization for Osteoarthritis
NA
Recruiting
20 participants
Started: Feb 1, 2022 · Completed: Feb 1, 2026
4 conditions
1 sponsor
1 location
NCT05725993
Longitudinal Assessment of Traumatic Microvascular Injury-2
N/A
Recruiting
110 participants
Started: Feb 1, 2022 · Completed: Mar 1, 2026
1 condition
2 sponsors
1 location
NCT06194695
DEB-TACE, Lenvatinib and Anti-PD(L)1 Antibody as Conversion Therapy for Intrahepatic Cholangiocarcinoma
N/A
Recruiting
100 participants
Started: Feb 1, 2022 · Completed: Jun 30, 2025
1 condition
3 sponsors
1 location
NCT04975776
Sleep Restriction Therapy for Insomnia in Primary Health Care
NA
Recruiting
200 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04441983
Foot/Ankle At 7T MRI
N/A
Recruiting
80 participants
Started: Feb 1, 2022 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT06348446
Tacrolimus Exposure in Kidney Transplantation
N/A
Recruiting
12,000 participants
Started: Feb 1, 2022 · Completed: Aug 30, 2024
1 condition
2 sponsors
4 locations
NCT05252897
Timing of Necrosectomy After Endoscopic Drainage of Walled-off Pancreatic Necrosis (WON)
NA
Recruiting
108 participants
Started: Feb 1, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
9 locations
NCT05183178
Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome
PHASE4
Recruiting
16,000 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2025
1 condition
7 sponsors
1 location
NCT05235009
LEVANTIS-0087A: GAGomes for Multi-Cancer Early Detection in Asymptomatic Adults (LEV87A)
N/A
Recruiting
9,170 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT04924088
Medical-legal Partnerships to Prevent Evictions and Homelessness Among Veterans
NA
Recruiting
300 participants
Started: Feb 1, 2022 · Completed: Oct 30, 2026
2 conditions
2 sponsors
1 location
NCT05559450
Blinatumomab as a Bridge to Allo-HSCT in HR BCP-ALL
PHASE2
Recruiting
80 participants
Started: Feb 1, 2022 · Completed: Jan 31, 2026
1 condition
7 sponsors
1 location
NCT05368987
Neuromodulation of the Fear Extinction Circuit Using Temporally and Anatomically Specific TMS in Humans
NA
Recruiting
250 participants
Started: Feb 1, 2022 · Completed: Sep 30, 2027
1 condition
2 sponsors
1 location
NCT05216809
Oral 'Breath Test' to Measure Anabolic Sensitivity in Young and Older Adults at Different Activity Levels
NA
Recruiting
32 participants
Started: Feb 1, 2022 · Completed: Mar 31, 2024
5 conditions
1 sponsor
1 location
NCT05235867
Secretin in Refeeding
N/A
Recruiting
10 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT04770870
Post Approval Study2: Hintermann Series H3 Total Ankle Replacement System
NA
Recruiting
232 participants
Started: Feb 1, 2022 · Completed: Apr 30, 2029
3 conditions
1 sponsor
10 locations
NCT05214261
Laparoscopic-guided TAP Block vs Epidural Analgesia
NA
Recruiting
210 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT07146256
Natural History of Oculo-Pharyngeal Muscular Dystrophy (OPMD) - Israel National OPMD Registry
N/A
Recruiting
300 participants
Started: Feb 1, 2022 · Completed: Jan 31, 2030
1 condition
2 sponsors
1 location
NCT04933370
Neuromodulation Parameter Efficacy
NA
Recruiting
20 participants
Started: Feb 1, 2022 · Completed: Jul 1, 2026
1 condition
1 sponsor
1 location
NCT05169268
Real-life Assessment of Abilify Maintena + Rexult in Schizophrenia
N/A
Recruiting
10 participants
Started: Feb 1, 2022 · Completed: Jan 31, 2026
2 conditions
1 sponsor
1 location
NCT05503667
Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma
PHASE2
Recruiting
96 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2028
3 conditions
1 sponsor
1 location
NCT05953077
The Effect of Prior Learning on Treatment of Morpheme Errors
NA
Recruiting
32 participants
Started: Feb 1, 2022 · Completed: Apr 30, 2025
1 condition
1 sponsor
1 location
NCT05241249
Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma
PHASE2
Recruiting
37 participants
Started: Feb 1, 2022 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT05146609
Acceptance of Hepatitis C Screening by Self-testing in High Risk and General Population
NA
Recruiting
1,384 participants
Started: Feb 1, 2022 · Completed: Jun 30, 2024
1 condition
1 sponsor
1 location
NCT04561986
TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients
PHASE3
Recruiting
50 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2028
1 condition
9 sponsors
8 locations
NCT05142683
Effectiveness of an Integrated Care Pathway for Depression: Cluster Randomized Controlled Trial
NA
Recruiting
300 participants
Started: Feb 1, 2022 · Completed: Sep 30, 2027
1 condition
3 sponsors
1 location
NCT05262023
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL593 in Healthy Participants and Participants With Frontotemporal Dementia (FTD-GRN)
PHASE1/PHASE2
Recruiting
106 participants
Started: Feb 1, 2022 · Completed: Nov 30, 2028
1 condition
2 sponsors
32 locations
NCT05138380
Hip Osteoarthritis and Foot Orthoses Trial (HOOT)
NA
Recruiting
28 participants
Started: Feb 1, 2022 · Completed: Oct 26, 2025
1 condition
1 sponsor
1 location
NCT05282381
Evaluation of Regret in Kidney Transplantation
N/A
Recruiting
250 participants
Started: Feb 1, 2022 · Completed: Jul 31, 2025
2 conditions
1 sponsor
1 location
NCT05124457
DETERMINE: Detemir vs NPH
PHASE2
Recruiting
336 participants
Started: Feb 1, 2022 · Completed: Jun 30, 2025
2 conditions
1 sponsor
1 location
NCT06533943
"Blue-green Space Physical Activity: the Parco Del Mare Study"
NA
Recruiting
30 participants
Started: Feb 1, 2022 · Completed: Dec 20, 2024
3 conditions
1 sponsor
1 location
NCT04461301
Multimodal Prehabilitation for Surgery in the Elderly: a Randomised, Prospective, Multicenter, Multidisciplinary Trial
NA
Recruiting
466 participants
Started: Feb 1, 2022 · Completed: Dec 30, 2026
2 conditions
3 sponsors
1 location
NCT05321355
Mainz Register of Patients With Sleep Disorders
N/A
Recruiting
500 participants
Started: Feb 1, 2022 · Completed: Jan 31, 2030
9 conditions
1 sponsor
1 location
NCT04820335
Promoting Independence With Compensatory Cognitive Rehabilitation
NA
Recruiting
65 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05126823
Efficacy of a Combined ACT+ App Intervention to Improve Psychological Flexibility and Associated Symptoms in Cancer Patients
NA
Recruiting
120 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05779319
1000 Eyes Lens Biometry Study: Artificial Intelligence for Intraocular Lens Power Calculation
N/A
Recruiting
1,000 participants
Started: Feb 1, 2022 · Completed: Sep 30, 2025
1 condition
4 sponsors
1 location
NCT05253495
Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma
PHASE2
Recruiting
80 participants
Started: Feb 1, 2022 · Completed: Jun 30, 2028
2 conditions
1 sponsor
3 locations
NCT05760664
Exercises Directed To Dynamic Stiffness Of The Thoracolumbar Region And Performance Of Amateur Runners
NA
Recruiting
99 participants
Started: Feb 1, 2022 · Completed: Jul 30, 2025
1 condition
1 sponsor
1 location
NCT05282654
Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions
NA
Recruiting
1,300 participants
Started: Feb 1, 2022 · Completed: Oct 15, 2026
2 conditions
2 sponsors
2 locations
NCT03175718
INPWT on Wound Complications & Clinical Outcomes After Lower Extremity Sarcoma Surgery Preop Radiation Therapy Patients
NA
Recruiting
291 participants
Started: Feb 1, 2022 · Completed: Apr 28, 2026
2 conditions
1 sponsor
2 locations
NCT05146362
Vermont RETAIN Impact Evaluation
NA
Recruiting
2,040 participants
Started: Feb 1, 2022 · Completed: Feb 28, 2026
1 condition
2 sponsors
1 location
NCT05242055
Integrated Diagnosis and Treatment of CKD on Outcomes
N/A
Recruiting
1,000 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2026
7 conditions
1 sponsor
1 location
NCT04773470
Implementation of FEES in Spinal Muscle Atrophy
NA
Recruiting
79 participants
Started: Feb 1, 2022 · Completed: Sep 30, 2024
1 condition
1 sponsor
1 location
NCT05999370
Prehabilitation for Colorectal Cancer Patients With Low Functional Capacity and Malnutrition
NA
Recruiting
60 participants
Started: Jan 31, 2022 · Completed: Dec 31, 2026
3 conditions
2 sponsors
1 location
NCT05209737
Trendelenburg As a First-line Intervention in Critically Ill, Sedated, Invasively Mechanically Ventilated, Hypotensive Patients
NA
Recruiting
50 participants
Started: Jan 31, 2022 · Completed: Oct 20, 2026
2 conditions
1 sponsor
2 locations
NCT05034887
Phase 2 Study of Trastuzumab Deruxtecan in the Neoadjuvant Treatment, or Trastuzumab Deruxtecan Plus Capecitabine Plus Durvalumab(MEDI4736) in the Preoperative and Postoperative Adjuvant Treatment for Patients with HER2 Positive Gastric and Gastroesophageal Junction Adenocarcinoma
PHASE2
Recruiting
64 participants
Started: Jan 31, 2022 · Completed: Mar 31, 2029
2 conditions
2 sponsors
1 location
NCT06844032
Predictors of Poor Prognosis in HFpEF
N/A
Recruiting
400 participants
Started: Jan 31, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04900493
The Rett Syndrome Global Registry
N/A
Recruiting
5,000 participants
Started: Jan 31, 2022 · Completed: Jun 30, 2031
1 condition
7 sponsors
1 location
NCT05162794
Is Laparoscopic Excision for Peritoneal Endometriosis Helpful or Harmful?
NA
Recruiting
100 participants
Started: Jan 31, 2022 · Completed: Jul 1, 2026
1 condition
3 sponsors
5 locations
NCT04149743
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
NA
Recruiting
420 participants
Started: Jan 31, 2022 · Completed: Dec 31, 2024
1 condition
3 sponsors
2 locations
Previous
1
More pages
1028
1029
1030
1031
1032
1033
1034
More pages
1333
Next